Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
ConditionMyasthenia Gravis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHealthPartners Institute
About this trial
The overall purpose of this pilot study is to examine the feasibility, acceptability, and tolerability of light and moderate intensity exercise in adults with MGeffect of light vs. moderate intensity exercise on health outcomes. Participants will be enrolled into the NeuroWell exercise program, which is geared toward individuals with neurological disorders or injuries and led by Certified Exercise Physiologists (CEPs) at the HealthPartners Neuroscience Center. A total of 20 people with MG will be enrolled in this study and participate in a small group exercise program 3 times a week for 12 weeks. Participants will be randomized into two exercise groups: 1) Light intensity or 2) Moderate intensity. We hypothesize that light and moderate intensity exercise will be feasible, acceptable, and tolerable in adults with MG and that individuals in the light intensity exercise group will be able to achieve the same improvement in health outcomes as the moderate intensity group.
Eligibility criteria
Qualifiers
Ability to provide and provision of signed and dated informed consent form.
Age 18-80
Diagnosis of generalized MG.
On a stable MG prescription medication regimen for the last 3 months.
Disqualifiers
Non-English speaking
Regular exercise participation within the month prior to study enrollment or any outside exercise participation during the study intervention period.
Significant cognitive impairment of any etiology that would impact study participation.
History of heart failure, chronic lung disease, angina or any other condition that causes unreasonable shortness of breath on exertion.
Trial design
Treatments tested in this trial
- Light Intensity Exercise
- Moderate Intensity Exercise
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov